Immunocore Holdings plc Public Float
Immunocore Holdings plc (IMCR) had Public Float of $1.50 billion as of 2025-06-30, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-25
- 2025-06-30: Entity Public Float $1.50B.
- 2024-06-28: Entity Public Float $1.60B.
- 2023-06-30: Entity Public Float $2.70B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.50B 10-K · filed 2026-02-25 |
| 2024-06-28 | $1.60B 10-K · filed 2025-02-26 |
| 2023-06-30 | $2.70B 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |